GUANGDONG JIAYING PHARMACEUTICAL CO., LTD

Guangdong Jiaying Pharmaceutical Co., Ltd

002198

CNE1000008P1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
6.77 ^CNY	+1.04%		+2.89%	-7.01%

2023	Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021	CI
2023	Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Guangdong Jiaying Pharmaceutical Co., Ltd Announces Executive Appointments

August 03, 2021 at 03:42 pm EDT

Guangdong Jiaying Pharmaceutical Co. Ltd. at its EGM held on August 2, 2021 approved the appointment of Zhu Layi, Feng Biao, Huang Xiaoliang as non-independent directors; Xu Chi as independent director; and Lai Yicai as supervisor.

Latest news about Guangdong Jiaying Pharmaceutical Co., Ltd

Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021	Nov. 15	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Guangdong Jiaying Pharmaceutical Co., Ltd. Approves Management Appointments	23-06-19	CI
Resolutions on Supervisor Nomination by Guangdong Jiaying Venture Capital	23-06-16	CI
Guangdong Jiaying Venture Capital Submits Proposals Related to Supervisor Nominations	23-06-05	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Guangzhou Taiping Enterprise Management Partnership (Limited Partnership) signed the Share Transfer Agreement to acquire 5% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 195 million.	23-02-20	CI
Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit	23-01-18	MT
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Jiaying Pharmaceutical’s Profit Crashes 93% in 2021 Despite Revenue Growth	22-03-14	MT
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-11	CI
Liu Libiao completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing.	21-11-07	CI
Chen Shaobin completed the acquisition of 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong.	21-11-07	CI
Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing for approximately CNY 210 million.	21-11-01	CI
An unknown buyer agreed to acquire 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd for approximately CNY 430 million.	21-11-01	CI
Lin Shaobin signed cancelled the acquisition of 8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong, Huang Zhiyong and Huang Libing	21-10-31	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Guangdong New South Investment Co., Ltd. entered into a share transfer agreement to acquire a 12.21% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong, Huang Zhiyong and Huang Libing for approximately CNY 620 million.	21-10-13	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-13	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Announces Executive Appointments	21-08-03	CI
Guangdong Jiaying Pharmaceutical Co., Ltd announced that it expects to receive CNY 884.64 million in funding from Guangdong New South Medical Investment Development Co., Ltd.	21-06-16	CI

Chart Guangdong Jiaying Pharmaceutical Co., Ltd

Duration

Period

Chart Guangdong Jiaying Pharmaceutical Co., Ltd

More charts

Company Profile

GUANGDONG JIAYING PHARMACEUTICAL CO., LTD is a China-based company principally engaged in the research, development, manufacture and sales of Chinese patent medicine. The Companyâs main products include Chinese traditional preparations, powders, tablets, capsules and granules, which are mainly applied in the treatment of throat disease, cold, stomach disease and others, as well as for tonic nourish purpose and others. The Company distributes its products mainly in domestic market. Through its subsidiaries, the Company is also engaged in the operation and leasing of self-owned real estate.

Sector

Pharmaceuticals

Calendar

2024-04-26 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
GUANGDONG JIAYING PHARMACEUTICAL CO., LTD	-7.01%	469M
DONG-E-E-JIAO CO.,LTD.	+37.37%	6.05B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.69%	4.45B
TASLY PHARMACEUTICAL GROUP CO., LTD	-12.46%	3.06B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.12%	3.04B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.47%	2.58B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+36.06%	1.79B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.84%	1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.60%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.03%	1.54B

Alternative Medicine